CrushSCI.com
Journal Selection & Manuscript Polishing Services
HAEMOPHILIA journal cover Medicine
Back to journal directory

Review Cycle Records

HAEMOPHILIA

Wiley SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 22025 JCR Q2
118.2Average days
125Median days
24Fastest days
239Longest days
2162025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

153 days

Preimplantation Genetic Testing for Families at Risk of Haemophilia: Ten‐Year Single‐Centre Experience

AuthorsMimosa Mortarino; Isabella Garagiola; Valeria Nicotra; Alessandra Riccaboni; Cristina Guarneri; Edgardo Somigliana; Flora Peyvandi

Affiliations1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Fondazione Luigi Villa Milan Italy; 2. Medical Genetics Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy; 3. Infertility Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy; 4. Department of Pathophysiology and Transplantation Università Degli Studi di Milano Milan Italy

Source PDF DOI Publisher page
85 days

Accuracy of Factor VIII Assays for Measuring Damoctocog Alfa Pegol: A Comparative Analysis

AuthorsJudith C. A. Cluitmans; Piet Meijer; Sanna R. Rijpma; An K. Stroobants

Affiliations1. Department of Clinical Chemistry and Haematology Jeroen Bosch Hospital ’s‐Hertogenbosch the Netherlands; 2. Department of Laboratory Medicine, Radboudumc Laboratory for Diagnostics Radboudumc Nijmegen the Netherlands; 3. ECAT foundation Voorschoten the Netherlands; 4. Department of Laboratory Medicine, Laboratory of Haematology Radboudumc Nijmegen the Netherlands

Source PDF DOI Publisher page
73 days

Platelet Hyperreactivity May Contribute to Thrombotic Complications in Afibrinogenemia: A Case‐Based Observation

AuthorsLiqin Ling; Chaonan Liu; Qianyuan Luo; Xunbei Huang; Shuang Wang; Zhiyu Yu; Ting Liu; Wanjun Chen; Xiao Shuai; Jing Zhou

Affiliations1. Department of Laboratory Medicine, Clinical Laboratory Medicine Research Center West China Hospital, Sichuan University Chengdu China; 2. Sichuan Clinical Research Center for Laboratory Medicine Chengdu China; 3. Department of Blood Transfusion Bazhong Central Hospital Bazhong Sichuan China; 4. Department of Hematology, Institute of Hematology West China Hospital of Sichuan University Chengdu Sichuan China; 5. Department of Laboratory Medicine The First Affiliated Hospital of Guangzhou Medical University Guangdong China

Source PDF DOI Publisher page
141 days

Male Range of Motion Norms in the Haemophilia Joint Health Score Underrepresent the Severity of Joint Damage in Females

AuthorsMaria Barrett; Laura Singer‐Fox; Dianne Thornhill; Joanna Roybal; Beth Boulden Warren

Affiliations1. University of Colorado Hemophilia and Thrombosis Center Aurora Colorado USA

Source PDF DOI Publisher page
42 days

Exploratory Claims‐Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan

AuthorsAzusa Nagao; Fumikazu Shimamura; Kosuke Iwasaki

Affiliations1. Department of Hematology and Oncology Kansai Medical University Hospital Osaka Japan; 2. Milliman, Inc. Tokyo Japan

Source PDF DOI Publisher page
144 days

Utilisation and Perceived Value of Genetic Counsellors Within US Haemophilia Treatment Centres

AuthorsCaylynn Carls; Sumedha Ghate; Stefanie N. Dugan; Radhika N. Sawh; DeBran A. Tarver

Affiliations1. Joan H. Marks Graduate Program in Human Genetics Bronxville New York USA; 2. Hemophilia Outreach Center Green Bay Wisconsin USA; 3. Versiti Milwaukee Wisconsin USA; 4. Hemophilia Federation of America Washington District of Columbia USA

Source PDF DOI Publisher page
206 days

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross‐Sectional Study of Patient‐ and Joint‐Level Analyses Using Musculoskeletal Ultrasound

AuthorsTakeo Abe; Yusuke Inagaki; Chie Ogita; Yuko Minagawa; Taduko Tokugawa; Akihiro Sawada; Satoshi Higasa; Yoshitoshi Ohtsuka; Teppei Hashimoto; Naoto Azuma

Affiliations1. Department of Diabetes, Endocrinology and Clinical Immunology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan; 2. Department of Rehabilitation Medicine Nara Medical University Kashihara Nara Japan; 3. Department of Respiratory Medicine and Haematology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan; 4. Department of Paediatrics, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan

Source PDF DOI Publisher page
85 days

Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays

AuthorsMasahiro Takeyama; Yasuharu Nishida; Shoko Furukawa; Kenichi Ogiwara; Keiji Nogami

Affiliations1. Division of Hemophilia National Hospital Organization Osaka National Hospital Osaka Japan; 2. Department of Pediatrics Nara Medical University Kashihara Nara Japan

Source PDF DOI Publisher page
118 days

Perceived Barriers to Healthcare Access Among Paediatric Patients With Haemophilia in Cambodia: A Cross‐Sectional Survey

AuthorsChean Sophâl; Heng Sivmeng; Lean Kimsreng; Ith Ponndara

Affiliations1. Department of Pediatric Hematology and Immunology Hemophilia Treatment Center, National Pediatric Hospital Phnom Penh Cambodia; 2. Technical Office, National Pediatric Hospital Phnom Penh Cambodia; 3. Academic and Training Office University of Health Sciences Phnom Penh Cambodia

Source PDF DOI Publisher page
135 days

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH‐AHA‐EMI Study

AuthorsHalet Türkantoz; Christiane Dobbelstein; Richard Greil; Christina Hart; Robert Klamroth; Paul Knöbl; Johannes Oldenburg; Christian Pfrepper; Ulrich Sachs; Inga M. Schimansky; Karolin Trautmann‐Grill; Andreas Tiede

Affiliations1. Hematology, Haemostasis, Oncology, and Cell Therapy Hannover Medical School Hannover Germany; 2. IIIrd Medical Department, Salzburg Cancer Research Institute CCCIT; Cancer Cluster Salzburg Paracelsus Medical University Salzburg Salzburg Austria; 3. Department of Hematology and Oncology University Hospital Regensburg Regensburg Germany; 4. Internal Medicine, Vascular Medicine and Coagulation Disorders Vivantes Clinic Friedrichshain Berlin Germany; 5. Department of Medicine 1, Div. Hematology and Hemostasis Medical University of Vienna Vienna Austria; 6. Institute of Experimental Hematology and Transfusion Medicine University Hospital Bonn, Medical Faculty, University of Bonn Bonn Germany; 7. Division of Haemostaseology, Medical Department I University Hospital Leipzig Leipzig Germany; 8. Department of Thrombosis and Haemostasis Giessen University Hospital Giessen Germany; 9. Medical Clinic I University Hospital Carl Gustav Carus, TU Dresden Dresden Germany; 10. Clinical Chemistry and Laboratory Medicine Hannover Medical School Hannover Germany

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.